Epstein–Barr Virus Coopts Lipid Rafts to Block the Signaling and Antigen Transport Functions of the BCR  by Dykstra, Michelle L et al.
Immunity, Vol. 14, 57–67, January, 2001, Copyright ª 2001 by Cell Press
Epstein–Barr Virus Coopts Lipid Rafts
to Block the Signaling and Antigen
Transport Functions of the BCR
Signaling through the BCR alone is not sufficient to
mount a B cell response to T cell–dependent antigens
(reviewed by Parker, 1993). In addition, B cell activation
requires interactions of the B cell with CD41 helper T
cells, initiated by the T cell antigen receptor (TCR) en-
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gagement of antigenic peptide–MHC class II complexesNational Institutes of Health
on the surface of B cells (Germain, 1994). The BCR playsRockville, Maryland 20852
a key role in the processing and presentation of antigen†Department of Microbiology-Immunology
to helper T cells by efficiently internalizing antigen intoNorthwestern University Medical School
intracellular compartments where peptide–MHC class IIChicago, Illinois 60611
complexes are assembled (reviewed in Watts, 1997).
Current evidence indicates that the signaling and tar-
geting functions of the BCR are interrelated and thatSummary
signaling through the BCR influences its internalization
(reviewed in Wagle et al., 2000). Cross-linking of theThe B cell antigen receptor (BCR) functions to initiate
BCR by multivalent antigen or anti-Ig accelerates BCRsignaling and to internalize antigen for processing
internalization and increases the level of degradation offrom within Lyn kinase-enriched membrane lipid rafts.
the BCR compared with BCR-recognizing monovalentThe signaling function of the BCR is blocked by Ep-
antigen (Song et al., 1995; Cheng et al., 1999b). Thestein–Barr Virus (EBV) latent membrane protein 2A
accelerated transport can be blocked by suppressing(LMP2A), which is constitutively phosphorylated by
BCR signaling using inhibitors of kinases that play aLyn. Here, we show that LMP2A resides in lipid rafts
role in B cell activation (Wagle et al., 1998). Signalingand excludes the BCR from entering rafts by Lyn-
domains on Iga/b have been shown to strongly influencedependent mechanisms, thus blocking both BCR sig-
the rate of antigen targeting (Aluvihare et al., 1997). Innaling and antigen transport. Mutant LMP2A that per-
addition, BCR that lack both Iga and Igb are not correctlymits BCR signaling and raft translocation still blocks
targeted to antigen-processing compartments (Shaw etantigen trafficking, indicating independent control of
al., 1990; Mitchell et al., 1991; Grupp et al., 1993; Mitchellthese BCR functions. Thus, EBV coopts the lipid rafts
et al., 1995). The molecular mechanisms by which BCRto disarm both the signaling and antigen-processing
signaling and antigen targeting are linked are not knownfunctions of the BCR by independent mechanisms.
at present.
A mechanism by which signaling and antigen-tar-Introduction
geting functions of the BCR might be coordinated
was recently provided by the description of cholesterol-The B cell antigen receptor (BCR) plays two critical roles
and sphingolipid-rich plasma membrane microdomainsin the B cell response to T cell–dependent antigens:
termed lipid rafts. Rafts are proposed to function asinitiating a signal transduction cascade leading to the
platforms for both receptor signaling and traffickingtranscriptional activation of a variety of genes associ-
(Brown and Rose, 1992; Simons and Ikonen, 1997;ated with B cell activation and targeting antigen to endo-
Kurzchalia and Parton, 1999), and we recently providedcytic compartments where the antigen is processed and
evidence for lipid rafts in BCR signaling and antigenpresented with MHC class II molecules recognized by
targeting (Cheng et al., 1999a). Following cross-linking,
helper T cells (reviewed by Parker, 1993; Watts, 1997).
the BCR was shown to rapidly translocate into Lyn-
The BCR is composed of a surface Ig (sIg) noncovalently
enriched, CD45-deficient lipid rafts, where both the BCR
associated with the heterodimer Iga/b that functions as and Lyn become phosphorylated. Subsequently, the
the signaling component of the complex (reviewed by BCR targets bound antigen to the endocytic MHC class
Reth and Wienands, 1997). Antigen is recognized by II peptide-loading compartments. Targeting appears to
sIg, and cross-linking of the BCR by multivalent antigen be initiated from the lipid rafts, as a portion of the raft
leads to the phosphorylation of immune receptor tyro- constituent sphingolipid GM1 is internalized along with
sine-based activation motifs (ITAMs), present on the the BCR and trafficked to the MHC class II compart-
cytoplasmic domains of the Iga/b chains, by Lyn and ments. Thus, current evidence indicates that lipid rafts
other Src family kinases. The phosphorylated ITAMs function as platforms for both the signaling and antigen-
recruit the SH2 domain–containing kinase Syk, which in targeting functions of the BCR.
turn recruits a variety of signaling molecules, leading Given the importance of the signaling and antigen-
to the initiation of signaling cascades resulting in Ca21 trafficking functions of the BCR in B cell activation, it is
mobilization, transcription of gene products associated perhaps not surprising that these functions are targets of
with B cell activation, and cell proliferation (Cambier et pathogens that disarm the immune response, allowing
al., 1994; Gold and DeFranco, 1994; Pleiman et al., 1994; persistence of the organism. EBV establishes a persis-
Reth and Wienands, 1997). tent latent infection in a population of human resting B
cells that recent evidence indicates resembles memory
B cells (Miyashita et al., 1995; Miyashita et al., 1997;‡ To whom correspondence should be addressed (e-mail: spierce@
niaid.nih.gov). Babcock et al., 1998). During latent infection, the viral
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gene product LMP2A is expressed on the B cell surface or treated to cross-link the BCR, and lipid rafts were
isolated as previously described (Cheng et al., 1999a).(reviewed in Longnecker and Miller, 1996). Indeed,
Equal numbers of cells were incubated on ice with F(ab9)2LMP2A is the only viral protein that is consistently ex-
rabbit anti-human Ig, washed, and incubated with F(ab9)2pressed in latently infected resting B cells (Qu and Rowe,
anti-rabbit Ig to cross-link the BCR. Cells were lysed in1992; Tierney et al., 1994; Chen et al., 1995; Miyashita
1% Triton X-100 and subjected to discontinuous su-et al., 1997). LMP2A is a 12 transmembrane–spanning
crose density gradient centrifugation, and fractions 4integral membrane protein with cytoplasmic amino- and
and 11, previously shown to contain raft and solublecarboxy-terminal domains (Laux et al., 1988, 1989; Sam-
regions of the gradient, respectively (Cheng et al.,ple et al., 1989). The 119 amino acid amino-terminal
1999a), were subjected to SDS-PAGE and immunoblot-domain of LMP2A contains a variety of motifs involved
ting, probing for LMP2A. wt-LMP2A, which migrates asin protein–protein interactions, including eight tyrosine
a 54 kDa protein (Miller et al., 1995), was constitutivelyresidues, two of which form an ITAM (Miller et al., 1994b;
present in the raft regions from wt-LMP2A1 cells andLongnecker, 2000). LMP2A binds Lyn and the ZAP-70
absent in LMP2A2 cells (Figure 1A). Significantly, Y112-family tyrosine kinase Syk, and the phosphorylation of
LMP2A was also constitutively present in the raft frac-LMP2A correlates with its association with Lyn and Syk
tion, indicating that association with Lyn is not neces-(Longnecker and Miller, 1996). Tyrosine residue Y112
sary for LMP2A raft localization. Cross-linking the BCRand residues Y74 and Y85, which form the ITAM, have
did not alter the presence of either the wt- or Y112-been identified as being necessary for the binding of
LMP2A in the rafts (Figure 1A).LMP2A to Lyn and Syk, respectively (Fruehling and Long-
The lipid rafts from all three cell types also containednecker, 1997; Fruehling et al., 1998). The association of
Lyn but excluded the phosphatase CD45, and the loca-LMP2A with Lyn and Syk has been proposed to prevent
tion of these proteins was not altered by anti-Ig treat-these essential tyrosine kinases from participating in
ment (Figure 1A). The amount of Lyn recovered on theBCR signal transduction (Miller et al., 1995). Indeed,
density gradient from wt-LMP2A1 cells was less thancross-linking of the BCR in LMP2A-containing cells does
that from either LMP2A2 or Y112-LMP2A1 cells. Thisnot lead to phosphorylation of signaling molecules or
appears to be the case even though the amount of pro-Ca21 mobilization. BCR signaling is restored by muta-
tein recovered from the wt-LMP2A1 cells was greatertions of tyrosine Y112 within the cytoplasmic domain of
than that from either LMP2A2 or Y112-LMP2A1 cells,LMP2A that preclude LMP2A binding to Lyn (Miller et
as judged by the amount of tubulin present in the solubleal., 1993; Miller et al., 1994b; Fruehling et al., 1998).
fraction (Figure 1A). This observation is consistent withSignaling through LMP2A in the absence of a functioning
previous results indicating that the level of Lyn is down-BCR has been shown in a transgenic model to substitute
regulated in wt-LMP2A-containing cells due to a de-for at least a subset of the signals that allow B cell
crease in the relative half-life of Lyn (Ikeda et al., 2000).development and survival (Caldwell et al., 1998, 2000).
Lipid rafts are cholesterol-rich microdomains, and, asHowever, at present, the nature of the LMP2A signal and
such, the integrity of lipid rafts is dependent on choles-its relationship to BCR signaling remain to be defined.
terol. To demonstrate that the presence of LMP2A inHere, we show that LMP2A is constitutively present
the gradient fractions that contain lipid rafts was depen-in lipid rafts of EBV-immortalized human B cell lines.
dent on cholesterol in the membrane, wt-LMP2A1LMP2A functions in the rafts to block the translocation
(721.114) cells were treated with the cholesterol-deplet-of the BCR into rafts and to block the subsequent signal-
ing agent methyl-b-cyclodextrin (MCD) at 378C anding and accelerated internalization of the BCR upon BCR
washed to remove MCD–cholesterol complexes. A por-cross-linking. The Y112 mutant LMP2A that cannot bind
tion of the cells was incubated in cholesterol-containingLyn allows BCR entry into rafts and signaling from the
media for 4 hr at 378C to allow cholesterol recovery. Therafts but blocks accelerated trafficking of the BCR upon
cells were then lysed in Triton X-100, and rafts were
cross-linking. These results indicate that the signaling
isolated by sucrose density gradient centrifugation. The
and targeting functions of the BCR rely on distinct mo-
lipid raft fraction was analyzed by SDS-PAGE and immu-
lecular mechanisms and that LMP2A has adopted sepa- noblotting, probing for LMP2A and Lyn. Treatment with
rate strategies to block these two functions of the BCR. MCD resulted in a complete loss of LMP2A and Lyn
from lipid rafts (Figure 1B). Following cholesterol recov-
Results ery, both LMP2A and Lyn were detected in the lipid raft
fractions in the cells, indicating that the localization of
Both Wild-Type and Y112-LMP2A Are Constitutively LMP2A within the lipid raft fraction is dependent on
Present in Rafts membrane cholesterol.
The location on the plasma membrane of LMP2A in The absolute amount of Y112-LMP2A present in the
untreated B cells and in B cells treated to cross-link the rafts appears less than that of wt-LMP2A. However, the
BCR was determined. LMP2A normally associates with percent of the total LMP2A present in the rafts of
the Src family kinase Lyn that is concentrated in lipid the cells expressing wt-LMP2A and Y112-LMP2A ap-
rafts, and both the wild-type LMP2A (wt-LMP2A) and a peared similar. To verify that the presence of LMP2A in
mutant version of LMP2A (Y112-LMP2A), which cannot the rafts is not dependent on association with Lyn, the
bind Lyn and does not block BCR signaling, were ana- amount of LMP2A in the rafts was determined for several
lyzed (Miller et al., 1994b, 1995; Longnecker and Miller, additional cell lines expressing either the wt-LMP2A or
1996; Fruehling et al., 1998). Y112-LMP2A (Figure 2). Quantification of the amount of
LMP2A2 cells (ES1) or cells expressing wt-LMP2A LMP2A in the raft and soluble regions of the sucrose
gradients showed that the percent of LMP2A in the rafts(721.114) or Y112-LMP2A (Y112) were either untreated
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Figure 1. Both WT- and Y112-LMP2A Consti-
tutively Localize to Lipid Rafts
(A) Equivalent numbers of LMP2A2 (ES1), wt-
LMP2A1 (721.114), and Y112-LMP2A1 (Y112)
cells were lysed at 48C in 1% Triton X-100
in TNE with phosphatase inhibitors, and the
lysates were subjected to discontinuous su-
crose gradient centrifugation. Fractions 4 and
11, previously determined to correspond to
the membrane raft fraction and soluble frac-
tion (Cheng et al., 1999a), were subjected to
10% SDS-PAGE and immunoblotting, prob-
ing with antibodies specific for LMP2A, Lyn,
and CD45, followed by secondary antibodies
and ECL. The soluble fraction contains the
majority of cellular proteins, and therefore, to
equalize protein concentration, one fourth of
the volume of fraction 11 was loaded, as com-
pared with that of fraction 4. Representative
blots from at least three separate experi-
ments are shown.
(B) WT-LMP2A1 cells were untreated or
treated with MCD (12.5 mM) for 16 min at
378C and washed to remove drug–cholesterol
complexes as previously described (Cheng et
al., 1999a). A portion of the cells was removed
and placed in cholesterol-containing media
for 4 hr to allow for cholesterol recovery. Raft
and soluble membrane fractions were ob-
tained and analyzed, as in (A), probing for
LMP2A and Lyn. The blots shown are repre-
sentative of at least four experiments.
varied little, averaging 18% of the total LMP2A for all of the LMP2A2 (ES1), wt-LMP2A1 (721.114) and Y112-
cell lines (Figure 2). In contrast, less than 1% of CD45 LMP2A1 (Y112) lines were incubated with [125I]Fab anti-
is present in the same raft fractions, indicating that the Ig to label the BCR in the presence or absence of cross-
presence of LMP2A in the rafts was selective and not linking antibodies. The cells were lysed and raft and
due to nonspecific contamination of the rafts by mem- soluble fractions isolated. The position of the BCR in
brane proteins. Similarly, tubulin was not detected in the gradient fractions was quantified by measuring the
the raft fractions of the gradient (data not shown). Thus, amount of [125I]Fab anti-Ig. The amount of BCR in lipid
mutation of the Lyn binding site in the LMP2A cyto- rafts from LMP2A2 cells increased z3-fold upon cross-
plasmic domain did not appear to significantly alter its linking (Figure 3A), consistent with results previously
raft localization. obtained with mouse B cell lines (Cheng et al., 1999a).
In all cell lines analyzed, a significant portion of both The presence of wt-LMP2A in lipid rafts blocked the
wt-LMP2A and Y112-LMP2A was present in the soluble translocation of the BCR into rafts. However, the BCR
region of the gradient (Figures 1 and 2). It is unclear efficiently translocated into lipid rafts containing Y112-
whether the presence of LMP2A in the soluble region LMP2A. To establish the generality of the finding, the
of the gradient reflects the inefficiency of raft isolation translocation of the BCR into lipid rafts was analyzed
in these cells under the conditions used or if LMP2A is for all eight of the cell lines described in Figures 1 and
actually present both in and out of lipid rafts on the 2. Horseradish peroxidase (HRP)-anti-Ig was used to
cell surface. However, the distribution of LMP2A in the cross-link the BCR, and the HRP activity in the gradient
gradient is similar to that reported for influenza virus fractions was quantified (Figure 3B). HRP activity was
HA, which is considered to be localized exclusively in localized in the raft regions (fractions 3–6) of the LMP2A2
lipid rafts (Scheiffele et al., 1997), suggesting that the (ES1) and each of the Y112-LMP2A1 cell lines (F.10,
raft isolation is somewhat inefficient. C.3, and Y112). In contrast, the BCR in each of the wt-
LMP2A1 cell lines (721.114, LCL1, WT.1, and WT.3) was
found in the soluble regions of the gradient (fractionsThe Effect of LMP2A on BCR Translocation
9–12). The BCR in the raft fractions following cross-into Rafts
linking was dependent on the affinity of the BCR for lipidTo determine the effect of wt-LMP2A and Y112-LMP2A
on the translocation of the BCR into lipid rafts, cells rafts and not on an artifact of aggregation, as CD45,
Immunity
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raft regions of the gradient obtained from cells not
treated with MCD. Treatment with MCD resulted in the
loss of HRP activity from the raft regions of the gradient,
indicating that the integrity of lipid rafts is necessary for
BCR localization to the Triton X-100–insoluble gradient
fractions. The effect of MCD was reversible, in that HRP
activity was detected in raft regions of gradients ob-
tained from cells allowed to recover from MCD treatment
by incubation for 4 hr in cholesterol-containing media.
The Effect of WT-LMP2A and Y112-LMP2A on the
Accumulation of Raft-Associated Phosphorylated
Proteins following BCR Cross-Linking
Previous studies showed that BCR translocation into
rafts resulted in the tyrosine phosphorylation of raft pro-
teins, including Iga and Lyn (Cheng et al., 1999a). To
explore the effect of LMP2A on the tyrosine phosphory-
lation of raft-associated proteins, LMP2A2 (ES1), wt-
LMP2A1 (721.114), and Y112-LMP2A1 (Y112) cells were
treated to cross-link the BCR, lysed, and subjected to
sucrose density gradient centrifugation. Raft fractions
were analyzed by SDS-PAGE and immunoblotting, prob-
ing with a phosphotyrosine-specific mAb (Figure 4A). In
the absence of BCR cross-linking, the LMP2A2 and
Y112-LMP2A1 cells showed an overall higher constitu-
tive level of tyrosine-phosphorylated proteins in the raft
fraction, as compared with wt-LMP2A1 cells. The de-
crease in steady-state phosphorylation in the raft frac-
tion of wt-LMP2A1 cells is likely due to the reduction
in Syk and Lyn kinase activity as previously described
(Miller et al., 1994a, 1995). Cross-linking the BCR re-
sulted in an increase in both the number of phosphory-
lated proteins as well as in the overall level of protein
Figure 2. The Ability of LMP2A to Bind Lyn Does Not Influence Raft
phosphorylation in the rafts from LMP2A2 cells. The lowLocalization
levels of tyrosine phosphorylation in the rafts from wt-(A) Equivalent numbers of cells of the wt-LMP2A-expressing cell
LMP2A1 cells were unchanged by BCR cross-linking.lines LCL1, WT.1, and WT.3 or the Y112-LMP2A-expressing cell
However, LMP2A1 cells do contain the machinery capa-lines F.10, C.3, and Y112 were lysed and subjected to discontinuous
sucrose gradient centrifugation as in Figure 1. Fractions 4–6, con- ble of tyrosine phosphorylation, as pervanadate treat-
taining the insoluble raft membranes, and fractions 10–12, con- ment that stimulates general protein phosphorylation
taining the soluble membranes, were subjected to SDS-PAGE and resulted in a modest but significant increase in the num-
immunoblotting, probing for LMP2A or CD45. To equalize protein
ber and level of tyrosine-phosphorylated proteins in theconcentrations, one fifth of the volume of fractions 10–12 was
rafts (Figure 4B). The tyrosine phosphorylation patternloaded, as compared with fractions 4–6.
in rafts obtained from Y112-LMP2A1 cells resembled(B) The amount of LMP2A and CD45 in each fraction was quantified
by densitometry, and the results are expressed as a percent of that in rafts from LMP2A2 cells, with an increase in
the total LMP2A or CD45 present in the raft regions. Shown is a the level of phosphorylation in rafts upon cross-linking
representative immunoblot of two independent experiments and the (Figure 4A). However, the phosphorylation patterns be-
quantification of that blot.
tween LMP2A2 and Y112-LMP2A1 cells were not identi-
cal, indicating that, although the BCR initiates signaling
in both LMP2A2 and Y112-LMP2A1 cells, the resultingwhich is excluded from lipid rafts, remains exclusively in
cascades may not be identical.the soluble fraction following cross-linking using CD45-
specific antibodies (Figure 3C).
To confirm that the presence of the BCR in Triton Both WT- and Y112-LMP2A Inhibit the Accelerated
Internalization of BCR upon BCR Cross-LinkingX-100–insoluble fractions of the gradient was due to the
association of the BCR with rafts, cells were treated with To determine the effect of wt- and Y112-LMP2A on BCR
internalization and degradation, the internalization ofMCD to disrupt lipid rafts before lysis and raft isolation.
LMP2A2 (ES1) cells were incubated with MCD, and a [125I]Fab anti-Ig was followed in LMP2A2 (ES1), wt-
LMP2A1 (721.114), and Y112-LMP2A1 (Y112) cells. Theportion of the MCD-treated cells was washed and incu-
bated for 4 hr at 378C in cholesterol-containing media BCR was labeled with [125I]Fab at 48C, and the cells were
untreated or treated with anti-Ig to cross-link the BCR.to allow for cholesterol recovery. The cells were treated
to cross-link the BCR using HRP-anti-Ig, lysed, and sub- The cells were washed and warmed at 378C for various
lengths of time. The radioactivity present inside the cellsjected to discontinuous sucrose density centrifugation.
The HRP activity was measured in each of the gradient (internalized) or released from the cells as trichloroacetic
acid (TCA)-soluble material (degraded) was measuredfractions (Figure 3D). HRP activity was present in the
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and presented as a percentage of the total radioactivity
associated with the cells before warming (Figure 5). The
BCR in LMP2A2 cells was internalized at an accelerated
rate upon anti-Ig treatment, with maximal levels of BCR
internalization (35%) achieved at 10 min after warming.
In the absence of cross-linking, similar levels of BCR
internalization were not achieved until nearly 60 min of
incubation at 378C. Significantly, the presence of wt-
LMP2A in cells blocked the accelerated internalization of
the BCR upon cross-linking. Similarly, BCR-accelerated
internalization was blocked by Y112-LMP2A (Figure 4).
In both wt-LMP2A2 and Y112-LMP2A1 cell lines, the
maximal levels of BCR internalization (z20%) were lower
than those obtained with LMP2A2 cells.
In addition to accelerating the rate of BCR internaliza-
tion, BCR cross-linking in LMP2A2 cells resulted in a
larger fraction of BCR (15% by 40 min) being degraded,
as compared with untreated cells (Figure 5). In cells
containing wt-LMP2A, cross-linking the BCR had no
effect on BCR degradation. In contrast, in the presence
of Y112-LMP2A, the fraction of the BCR degraded upon
cross-linking was significantly increased and reached
levels similar to that in LMP2A2 cells. Taken together,
these results indicate that both the wt- and Y112-LMP2A
blocked accelerated internalization, but only the wt-
LMP2A blocked degradation, indicating that these two
BCR activities were independently regulated.
The Role of Src Family Kinases in BCR Signaling,
Raft Translocation, and Internalization
The results described above indicate that the inability
of Y112-LMP2A to associate with Lyn allowed BCR
translocation into lipid rafts and subsequent degrada-
tion of the BCR. This observation suggested a relation-
ship between Lyn kinase activity and these BCR func-
tions. To further delineate the requirements for kinase
activity for BCR raft translocation, the effect of the Src
Figure 3. WT-LMP2A Blocks BCR Raft Translocation
(A) The BCR on LMP2A2 (ES1), wt-LMP2A1 (721.114), and Y112-
LMP2A1 (Y112) cells was labeled with [125I]Fab anti-Ig and cross-
linked or not with HRP-anti-Ig at 48C. Cells were lysed and rafts
isolated by discontinuous sucrose density gradient centrifugation.
The cpm were measured in each fraction, and the amount present
in raft fractions 3–6 was expressed as the percent of the total cell-
associated 125I. Plotted are means and SEM from at least three
independent experiments.
(B) The location of the BCR following cross-linking in each of the
eight cell lines shown in Figures 1 and 2 was determined. The BCR
was cross-linked using HRP-anti-Ig at 48C, the cells lysed, and the
rafts and soluble membrane fractions isolated as in (A). The HRP
activity in the fractions is given and is representative of at least two
separate experiments.
(C) LMP2A2 cells were treated with HRP-anti-Ig or HRP-anti-CD45
prior to raft isolation by sucrose density gradient centrifugation. The
HRP activity in each fraction was measured. Shown is a representa-
tive of three independent experiments.
(D) LMP2A2 cells were untreated or pretreated with MCD (12.5 mM)
for 16 min at 378C and washed to remove drug–cholesterol com-
plexes. Half of the cells were allowed to recover by incubation in
cholesterol-containing media for 4 hr. The cells were treated with
HRP-anti-Ig, lysed, and the lysates subjected to discontinuous su-
crose gradient centrifugation. The HRP activity in each fraction was
measured. The data shown represent at least three independent
experiments.
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To ensure that incubation with PP2 inhibited BCR
signaling upon cross-linking, raft fractions were sub-
jected to SDS-PAGE and immunoblotting, probing with
a phosphotyrosine-specific mAb. BCR cross-linking in
untreated cells resulted in an increase in phosphoryla-
tion in the rafts of LMP2A2 and Y112-LMP2A1 cells but
not in the rafts of wt-LMP2A1 cells (Figure 6A). Treat-
ment with PP2 reduced the levels of raft-associated
phosphorylation following BCR cross-linking in LMP2A2
and Y112-LMP2A1 cells.
Upon cross-linking in the absence of PP2, the BCR
translocated into lipid raft regions in LMP2A2 and Y112-
LMP2A1 but not in wt-LMP2A1 cells. Incubation with
PP2 did not inhibit the cross-linking-induced translo-
cation of BCR into lipid raft regions in either LMP2A2
or Y112-LMP2A1 cells, indicating that BCR signaling
through Src family kinases is not necessary for BCR raft
translocation (Figure 6B). Indeed, the percent of the BCR
in lipid rafts was increased in anti-Ig-treated cells in the
presence of PP2, suggesting that translocation or stable
residency in rafts may be negatively regulated by Src
family kinases. Incubation with PP2 had no effect on
BCR raft localization in wt-LMP2A1 cells, and only a
small percentage of BCR was isolated in the raft regions
of these cells under all conditions.
The effect of PP2 on the internalization and degrada-
tion of the BCR was analyzed. The accelerated internal-
ization of BCR induced by cross-linking was blocked in
LMP2A2 cells by incubation with either 50 or 100 mM PP2
(Figure 6C), reducing the levels of BCR internalization to
constitutive levels. PP2 treatment had no effect on the
internalization of BCR in wt-LMP2A1 (data not shown)
or Y112-LMP2A1 cells (Figure 6C), neither of which inter-
nalized their BCR in an accelerated fashion upon BCR
cross-linking.
Treatment with PP2 inhibited degradation of the BCR
in LMP2A2 cells in a dose-dependent fashion, although
degradation was not reduced to constitutive levels at
the highest concentration tested (100 mM) (Figure 6C).
Figure 4. Phosphorylated Proteins Do Not Accumulate in Rafts of Treatment of Y112-LMP2A1 cells inhibited BCR degra-
WT-LMP2A1 Cells upon BCR Cross-Linking
dation upon cross-linking to levels resembling basal
(A) LMP2A2 (ES1), wt-LMP2A1 (721.114), and Y112-LMP2A1 (Y112) degradation (Figure 6C). Incubation with PP2 had no
cells were untreated or treated with anti-Ig, and raft fractions were
effect on BCR degradation in anti-Ig-treated wt-LMP2A1isolated and subjected to 10% SDS-PAGE, as described in Figure
cells (data not shown), which did not show increased1. The resulting gels were transferred to polyvinylidenedifluoride
(PVDF) and immunoblotted, probing with an HRP-labeled phospho- degradation of BCR upon cross-linking. Taken together,
tyrosine-specific antibody, followed by ECL. these results indicate that accelerated targeting and
(B) Rafts were isolated by discontinuous sucrose gradient centrifu- degradation of the BCR are dependent on kinase activity
gation from wt-LMP2A1 (721.114) cells untreated or treated with but that the signaling requirements for targeting and
anti-Ig or pervanadate. Gradient fraction 4 was subjected to 10%
degradation are not identical.SDS-PAGE and immunoblotting, probing with an HRP-labeled phos-
photyrosine-specific antibody, followed by ECL. Shown are repre-
sentative blots from at least three independent experiments. Discussion
Recently, attention has focused on sphingolipid- and
cholesterol-rich plasma membrane microdomains orfamily kinase inhibitor PP2 (Hanke et al., 1996) on BCR
translocation was assessed. LMP2A2 (ES1), wt-LMP2A1 lipid rafts and their roles in signal transduction and
membrane trafficking in immune cells. Current evidence(721.114), and Y112-LMP2A1 (Y112) cells were preincu-
bated with 50 or 100 mM PP2, and the BCR was labeled suggests that lipid rafts function as platforms for both
signaling and trafficking of the multichain immune rec-with [125I]Fab and cross-linked with anti-Ig in the contin-
ued presence of PP2. The cells were lysed and subjected ognition receptors, including the BCR, the TCR, and the
IgE receptor (reviewed in Langlet et al., 2000). For Bto discontinuous sucrose density centrifugation. The
percent of BCR present in lipid rafts was determined by cells, the rafts have been shown, thus far, to concentrate
the Src family kinase Lyn and a newly discovered Srcmeasuring the counts per minute (cpm) associated with
raft fractions 3–6. family kinase regulator, Cbp (Brdicka et al., 2000; Kawa-
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Figure 5. The WT- and Y112-LMP2A Differ-
entially Affect BCR Internalization
The BCR on LMP2A2 (ES1), wt-LMP2A1
(721.114), and Y112-LMP2A1 (Y112) cells
were labeled with [125I]Fab anti-Ig and cross-
linked or not with F(ab9)2 anti-Ig at 48C. The
cells were washed and incubated at 378C for
various lengths of time. At the end of each
time point, the cells were washed, saving the
supernatant, and acid stripped to remove
[125I]Fab remaining on the cell surface. The
radioactivity associated with the cells follow-
ing stripping was measured and taken as the
internalized fraction. The incubation media
was treated with TCA and centrifuged to re-
move precipitates. The cpm associated with
TCA-soluble material were measured and
taken as the degraded fraction. The internal-
ized and degraded fractions are expressed
as the percent of the total radioactivity asso-
ciated with the cells at each time point before
washing and stripping. Plotted are means and
SEM from at least three independent experi-
ments.
buchi et al., 2000), and to exclude the phosphatase insights into the mechanisms underlying BCR functions.
A summary of the findings is depicted in Figure 7.CD45. It is likely that other key elements of the BCR
signaling pathway also are concentrated in rafts. As The first observations involve the molecular require-
ments for BCR raft translocation. Following cross-link-depicted in Figure 7, following antigen-induced cross-
linking, the BCR rapidly translocates into lipid rafts, ing, the BCR was not associated with rafts in cells ex-
pressing wt-LMP2A. We interpret this to represent awhere it is phosphorylated and subsequently internal-
ized from the raft into endocytic compartments in the wt-LMP2A-induced block in BCR translocation and refer
to it as such, although it is possible that the BCR translo-cell. BCR internalized from the rafts has been shown
to be rapidly transported to MHC class II–containing cates into the raft but is only weakly associated with
the raft. The physical presence of LMP2A in rafts wascompartments, where antigen peptide–MHC class II
complexes are assembled (Song et al., 1995; Cheng not sufficient to block BCR entry into rafts, since BCR
translocated into rafts containing Y112-LMP2A. Sinceet al., 1999a, 1999b). Internalization may also result in
receptor degradation, resulting in BCR downregulation Y112-LMP2A does not associate with Lyn or block BCR
signaling, it is tempting to suggest that the block in BCRand cessation of signaling. Here, we provide evidence
that a B cell tropic virus, EBV, targets not the BCR translocation by wt-LMP2A was due to its inhibition of
BCR signaling. However, the Src family kinase inhibitordirectly but rather the B cell lipid raft to disrupt both the
signaling and antigen-targeting functions of the BCR. PP2 that blocked BCR signaling did not block BCR
translocation into rafts. Conversely, PP2 did not permitThe coopting of the lipid raft by a pathogenic virus lends
additional support for the physiological relevance of the raft translocation of the BCR in wt-LMP2A1 cells. A
higher percentage of BCR was isolated in lipid rafts inrafts in B cells. In addition, the mechanisms by which
EBV blocks BCR function from within rafts have allowed LMP2A2 and wt-LMP2A1 cells after treatment with PP2,
suggesting a possible negative regulation of BCR trans-a further dissection of the BCR signaling and trafficking
pathways. location by Src family kinases. Thus, the initiation of
BCR signaling through Src family kinases is not requiredThe molecular mechanisms underlying BCR raft trans-
location, signaling, and transport of antigen are, at pres- for BCR raft translocation, and the inhibition of raft trans-
location by wt-LMP2A is not due to the effect of wt-ent, not well defined. The results presented here, investi-
gating the effects of both a wild-type and mutant LMP2A LMP2A on BCR signaling. The results also indicate that
Lyn activity is not required for stable residency of eitheras well as a specific Src kinase inhibitor on BCR translo-
cation into rafts and internalization, provided several LMP2A or the translocated BCR in the lipid rafts.
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Figure 6. The Effect of the Src Family Kinase Inhibitor PP2 on BCR Raft Translocation and Internalization
(A) The BCR on LMP2A2 (ES1), wt-LMP2A1 (721.114), and Y112-LMP2A1 (Y112) cells were labeled with [125I]Fab anti-Ig. The cells were treated
with anti-Ig to cross-link the BCR in the presence or absence of 50–100 mM PP2. Raft fractions were isolated and subjected to 10% SDS-
PAGE and immunoblotting, as described in Figure 1, probing with an HRP-labeled phosphotyrosine-specific antibody, followed by ECL. Shown
is a representative blot from at least two independent experiments.
(B) The cpm were measured in the fractions from (A), and the amount present in raft fractions 3–6 was expressed as the percent of the total
cell-associated 125I. Plotted are means and SEM from at least two independent experiments for each cell type.
(C) BCR internalization and degradation was followed as described in Figure 5 in LMP2A2 (ES1) and Y112-LMP2A1 (Y112) cells treated with
anti-Ig in the presence or absence of 50–100 mM PP2. Plotted are means and SEM from at least three independent experiments.
The results presented here also address the require- all cases, the ability of the BCR to signal was necessary
for its increased degradation upon cross-linking. In-ments for BCR antigen targeting. The BCR was not inter-
nalized at an accelerated rate from the cell surface un- creased degradation of the BCR may reflect a down-
modulation of the BCR in response to signaling. Thisless BCR raft translocation and signaling occurred.
Thus, in the presence of wt-LMP2A or of the inhibitor downmodulation may be separate from the specialized
antigen trafficking of the BCR that accompanies acceler-PP2, both of which blocked BCR signaling, the BCR
was cleared from the surface at a slow constitutive rate. ated internalization and for which little antigen degrada-
tion is measured. Thus, downmodulation and measur-However, BCR raft translocation and signaling were not
sufficient for accelerated internalization of the BCR, able receptor degradation in lysosomes and accelerated
transport of antigen to the MHC class II peptide-loadingsince Y112-LMP2A, which did not block BCR raft trans-
location or BCR signaling, blocked BCR-accelerated in- compartments may be distinct outcomes of BCR anti-
gen binding.ternalization. Thus, the accelerated transport of the BCR
has requirements in addition to raft translocation and A final issue raised by the results presented here is
the physiological role of the observed block in BCRsignaling. In addition, LMP2A interferes with BCR inter-
nalization by a mechanism that is independent of its function by LMP2A. EBV establishes latency in human
hosts in a population of resting B cells, recently de-association with Lyn.
A previously unappreciated aspect of BCR function scribed as having a phenotype resembling that of the
memory B cell pool (Miyashita et al., 1995, 1997; Bab-suggested by the findings of this study is that the accel-
erated internalization and increased degradation of the cock et al., 1998). In order to achieve latent infection in
this memory-like pool, EBV must either infect memoryBCR upon cross-linking are separable events. This is
evidenced by the observations that Y112-LMP2A blocked B cells themselves or, alternatively, drive infected B cells
to differentiate into memory B cells. Thus, EBV mustBCR-accelerated transport but did not affect the in-
creased degradation of the BCR upon cross-linking. provide signals that promote survival of latently infected
memory cells. If EBV does not infect memory B cellsSimilarly, in the presence of the inhibitor PP2, acceler-
ated internalization of the BCR was completely blocked, but drives infected cells to a memory-like state, the virus
must, in addition, ensure that signals are provided towhile BCR degradation was only partially inhibited. In
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Figure 7. LMP2A Targets Lipid Rafts, Blocking Both the Signaling and Antigen Transport of the BCR
Upon cross-linking by antigen, the BCR rapidly translocates into plasma membrane lipid rafts, where signaling and internalization for degradation
and antigen transport are initiated. The chart depicts a summary of the effects of wt-LMP2A, Y112-LMP2A, and the Src family kinase inhibitor
PP2 on each BCR function. As shown, EBV blocks all steps in the pathway. The results also lead to the conclusions that the BCR translocation
into rafts is independent of signaling and that internalization leading to degradation and to accelerated transport for processing are independent
outcomes of antigen binding.
allow differentiation of infected cells. In either scenario, helper T cells. By blocking BCR signaling, LMP2A en-
sures persistence in this quiescent state. Moreover, bythe virus must ensure that infected cells are not elimi-
nated by the immune system. blocking trafficking of antigen, LMP2A further guaran-
tees a block in antigen presentation. Blocking B cellLMP2A is the only viral product that is consistently
detected in EBV latently infected cells (Qu and Rowe, activation also could have the important repercussion
of regulating the number of infected B cells by inhibiting1992; Tierney et al., 1994; Chen et al., 1995; Miyashita
et al., 1997), suggesting that it is responsible for estab- antigen-driven expansion. Further refinement of the
model for LMP2A function may add to an understandinglishing the conditions required for EBV persistence dur-
ing latent infection. Transgenic models have shown that of the mechanisms by which EBV persists in human B
cells during latent infection.LMP2A provides B cells with development and survival
signals that normally proceed from the BCR (Caldwell
et al., 1998, 2000). Thus, LMP2A is presumably capable Experimental Procedures
of promoting survival of latently infected B cells. In addi-
Cell Lines, Antibodies, and Reagentstion, it is possible that signals initiated from LMP2A
The EBV-infected LMP2A1 human lymphoblastoid cell line (LCL)could mimic BCR signals normally necessary to drive
721.114 (DeMars et al., 1983) was maintained in DME supplementeddifferentiation to memory B cells in response to antigen
as previously described (Jelachich et al., 1984) and containing 15%
encounter. FCS (15% complete media [15% CM]). The EBV-infected LMP2A2
In addition to providing signals that allow survival and LCL ES1 (Miller et al., 1994b, 1995) and the LCL Y112 (Fruehling et
al., 1998), expressing a mutant LMP2A carrying a Y112/F mutation,differentiation of B cells, LMP2A may also function in
were maintained in RPMI supplemented as above and containingthe establishment and persistence of EBV latency by
15% FCS (15% RPMI). Additional cell lines tested for the raft local-protecting infected cells from surveillance by the im-
ization of LMP2A and the BCR were LMP2A1 LCLs LCL1, WT.1, andmune system. The memory cells in which EBV persists
WT.3 and the Y112-LMP2A1 LCLs C.3 and F.10 (Longnecker et al.,
during latent infection are resting B7-negative cells (Mi- 1993; Fruehling et al., 1998). These additional lines were maintained
yashita et al., 1997; Babcock et al., 1999) and thus are in 15% RPMI.
Fab goat antibodies (specific for human g chain [Fab anti-Ig]),inherently ineffective as antigen-presenting cells for
Immunity
66
F(ab9)2 rabbit antibodies (specific for human IgA, G, and M), HRP- University of Cambridge, who provided the rat monoclonal antibody
YL1/2, specific for tubulin.conjugated F(ab9)2 goat antibodies (specific for rabbit IgG),
HRP-conjugated goat antibodies (specific for rabbit g chain), and
HRP-conjugated goat antibodies (specific for mouse g chain) were Received July 17, 2000; revised November 29, 2000.
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